149 related articles for article (PubMed ID: 11367725)
1. [Long-term efficacy of plasma-derived hepatitis B vaccine among Chinese children--a 12-year follow-up].
Liao S; Li R; Li H; Yang J; Zeng X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Apr; 20(2):89-94. PubMed ID: 11367725
[TBL] [Abstract][Full Text] [Related]
2. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
[TBL] [Abstract][Full Text] [Related]
3. [Long-term efficacy of vaccination against hepatitis B in newborns: 13 years' follow-up].
Wu W; Sun C; Jiang M; Xu Y; Zhang GH; Liu CB; Cao HL; Lin XM; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):239-41. PubMed ID: 11986695
[TBL] [Abstract][Full Text] [Related]
4. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
Wu Q; Zhuang GH; Wang XL; Wang LR; Li N; Zhang M
Vaccine; 2011 Mar; 29(12):2302-7. PubMed ID: 21277403
[TBL] [Abstract][Full Text] [Related]
5. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
Li H; Li R; Liao S; Yang J; Zeng X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
[TBL] [Abstract][Full Text] [Related]
6. [Long-term efficacy study of hepatitis B vaccination in newborns--results of 11 years' follow-up].
Lin X; Xu Z; Ou-Yang P
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Jun; 20(3):174-7. PubMed ID: 10682531
[TBL] [Abstract][Full Text] [Related]
7. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
8. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
[TBL] [Abstract][Full Text] [Related]
9. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
10. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and immune memory of plasma-derived hepatitis B vaccine 11 years after primary immunization].
Xu H; Zhuang G; Wang X; Chen Q; Chen Z
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Mar; 34(2):113-5. PubMed ID: 11860915
[TBL] [Abstract][Full Text] [Related]
12. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
[TBL] [Abstract][Full Text] [Related]
13. [Dynamic study on the anti-HBs level of immunized children born to HBsAg-positive and HBsAg-negative mothers in hyperendemic area of hepatitis B].
Gong J; Li RC; Li YP; Yang JY; Chen XR; Nong Y; Huang ZN; Li Q; Liu CB; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jan; 29(1):13-6. PubMed ID: 18785470
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the effectiveness nine years after primary immunization with local produced plasma-derived hepatitis B vaccine].
Xu H; Zuo H; Zhuang G
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):205-7. PubMed ID: 10322755
[TBL] [Abstract][Full Text] [Related]
15. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
16. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates.
Ding L; Zhang M; Wang Y; Zhou S; Kong W; Smego RA
Clin Infect Dis; 1993 Sep; 17(3):475-9. PubMed ID: 8218692
[TBL] [Abstract][Full Text] [Related]
17. [Seroepidemiological analysis of characteristic of hepatitis B virus in children after vaccination in Ningbo].
Chen H; Zhou A; Wang R
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):184-7. PubMed ID: 11860873
[TBL] [Abstract][Full Text] [Related]
18. [Follow-up on hepatitis B immunized neonates born to HBsAg positive mothers].
Zhang X; Xing Y; Shen L
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Mar; 32(2):97-9. PubMed ID: 10322808
[TBL] [Abstract][Full Text] [Related]
19. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
20. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
